$SLI Cashflow Statement | Understand Stock

$SLI

$1.40 -$0.03 (2.1%) Close

$SLI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 6 months to Dec 31, 2024	FY2023 12 months to Jun 30, 2024	FY2022 12 months to Jun 30, 2023	FY2021 12 months to Jun 30, 2022
Operating activities
Net (loss) income
Add items not affecting cash
Share-based compensation
Deferred income tax (benefit) expense
Unrealized foreign exchange loss (gain)
Impairment expense
Gain on deconsolidation of subsidiaries
Investment loss from Smackover Lithium
Fair value gain on Investment in Aqualung
Fair value gain on financial asset - FID
Amortization
Amortisation - office leases
Amortisation of pilot plant
Interest expense
Foreign exchange gain

Receivables
Prepaid expenses
Advances
Advances and deposits
Accounts payable and accrued liabilities
Receivables - unconsolidated affiliates
Accounts payable - unconsolidated affiliates
Other
Net changes in non-cash working capital items:
Other current assets
Other current assets and receivables
Advances and deposits
Accounts payable and accrued liabilities
Receivables - related parties
Accounts payable - related parties
Net cash used in operating activities
Investing activities
Smackover Lithium capital contributions
Exploration and evaluation assets
Proceeds received from disposal of subsidiaries
Aqualung Carbon Capture pilot plant development
Purchase of plant and equipment
Proceeds received from Equinor
Purchase of property, plant and equipment
Demonstration plant (formerly pilot plant)
Purchase of Aqualung Carbon Capture AS shares
Commercial plant development
Change in restricted cash
Patent
Net cash used in investing activities

Financing activities
Proceeds from private placement, net of costs
Proceeds from equity offering
Proceeds from at-the-market equity program
Exercise of options
Share issuance costs
Proceeds from private placement
Exercise of warrants
Lease payments
Net cash provided by financing activities

Effect of exchange rates on cash
Net change in cash
Cash, beginning of period
Cash, end of period
Non-cash investing and financing
Change in exploration and evaluation expenditures included in accounts payable
Additions to right-of-use assets
Change in share issuance costs included in accounts payable
Compensation shares issued
Change in proceeds from issuance of shares included in accounts receivable

Comments